A detailed history of Key Client Fiduciary Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Key Client Fiduciary Advisors, LLC holds 28,710 shares of PFE stock, worth $753,350. This represents 0.41% of its overall portfolio holdings.

Number of Shares
28,710
Previous 24,554 16.93%
Holding current value
$753,350
Previous $687,000 20.82%
% of portfolio
0.41%
Previous 0.38%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$27.7 - $31.39 $115,121 - $130,456
4,156 Added 16.93%
28,710 $830,000
Q2 2024

Jul 16, 2024

BUY
$25.26 - $29.6 $2,702 - $3,167
107 Added 0.44%
24,554 $687,000
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $61,152 - $70,222
2,362 Added 10.7%
24,447 $678,000
Q4 2023

Jan 09, 2024

SELL
$26.13 - $33.94 $17,167 - $22,298
-657 Reduced 2.89%
22,085 $635,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $53,397 - $62,416
1,664 Added 7.89%
22,742 $754,000
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $7,621 - $8,817
211 Added 1.01%
21,078 $773,000
Q1 2023

Apr 25, 2023

SELL
$39.39 - $51.28 $20,994 - $27,332
-533 Reduced 2.49%
20,867 $851,000
Q4 2022

Jan 17, 2023

BUY
$41.75 - $54.5 $451,150 - $588,927
10,806 Added 102.0%
21,400 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $1,837 - $2,243
42 Added 0.4%
10,594 $464,000
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $78,728 - $93,347
-1,692 Reduced 13.82%
10,552 $553,000
Q1 2022

Apr 18, 2022

BUY
$45.75 - $56.69 $73,017 - $90,477
1,596 Added 14.99%
12,244 $634,000
Q4 2021

Mar 01, 2022

BUY
$41.32 - $61.25 $439,975 - $652,190
10,648 New
10,648 $629,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Key Client Fiduciary Advisors, LLC Portfolio

Follow Key Client Fiduciary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key Client Fiduciary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Key Client Fiduciary Advisors, LLC with notifications on news.